Published online before print September 4, 2008

This Article Full Text Full Text (PDF) All Versions of this Article: ajpath.2008.080288v1 173/4/1165    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Siu, M. K.Y. Articles by Cheung, A. N.Y. PubMed PubMed Citation Articles by Siu, M. K.Y. Articles by Cheung, A. N.Y.

(American Journal of Pathology. 2008;173:1165-1172.)
© 2008 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2008.080288

Overexpression of NANOG in Gestational Trophoblastic Diseases

Effect on Apoptosis, Cell Invasion, and Clinical Outcome

Michelle K.Y. Siu^*, Esther S.Y. Wong^*, Hoi Yan Chan^*, Hextan Y.S. Ngan, Kelvin Y.K. Chan^* and Annie N.Y. Cheung^*

From the Departments of Pathology,^* and Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong Special Administrative Region, China

Gestational trophoblastic disease includes choriocarcinoma, a frankly malignant tumor, and hydatidiform mole (HM), which often leads to the development of persistent gestational trophoblastic neoplasia and requires chemotherapy. NANOG is an important transcription factor that is crucial for maintaining embryonic stem cell self-renewal and pluripotency. We postulated that NANOG is involved in the pathogenesis of gestational trophoblastic disease. In this study, significantly higher NANOG mRNA and protein expression levels, by quantitative PCR and immunoblotting, respectively, were demonstrated in HMs, particularly those that developed persistent disease, when compared with normal placentas. In addition, significantly increased nuclear NANOG immunoreactivity was found by immunohistochemistry in HMs (P < 0.001) and choriocarcinoma (P = 0.002). Higher NANOG expression levels were demonstrated in HMs that developed persistent disease, as compared with those that regressed (P = 0.025). Nuclear localization of NANOG was confirmed by confocal microscopy and immunoblotting in choriocarcinoma cell lines. There was a significant inverse correlation between NANOG immunoreactivity and apoptotic index assessed by M30 CytoDeath antibody (P = 0.012). After stable knockdown of NANOG in the choriocarcinoma cell line JEG-3 by an shRNA approach, increased apoptosis was observed in relation to with enhanced caspases and poly(ADP-ribose) polymerase activities. NANOG knockdown was also associated with decreased mobility and invasion of JEG-3 and down-regulation of matrix metalloproteases 2 and 9. These findings suggest that NANOG is involved in the pathogenesis and clinical progress of gestational trophoblastic disease, likely through its effect on apoptosis, cell migration, and invasion.

This article has been cited by other articles:

				I.-M. Shih and K.-T. Kuo Power of the Eternal Youth: Nanog Expression in the Gestational Choriocarcinoma Am. J. Pathol., October 1, 2008; 173(4): 911 - 914. [Abstract] [Full Text] [PDF]